Our Team

 

OUR TEAM

Douglas Crawford

Douglas Crawford, PhD

Managing Director, Mission Bay Capital
General Manager, QB3@953

Douglas Crawford’s goal is to help entrepreneurial scientists create successful startups. To this end, Doug and his colleagues have systematically lowered the barriers between great ideas and successful companies. For instance, Crawford created and manages QB3@953. This state-of-the-art co-working laboratory program in San Francisco allows entrepreneurs to rapidly generate data without getting bogged down in facility management. Rather than spending months getting a facility up and running, QB3@953 startups can generate important data in their first week.

In the first 3 years, this program has helped launch 94 companies that have raised over 1.36B. This incubator program reflects Doug’s passion for startups and his eagerness to help entrepreneurs overcome challenges.

Doug is also the Managing Director of Mission Bay Capital and has overseen the investment in 34 companies, 4 of which have already enjoyed successful exits (Calithera, iPierian, Redwood Biosciences and Zephyrus). He is a board member of Avexegen, Circle Pharma, Delpor, Invenio, Magnamosis, Magnap, SiteOne (observer), Tangible Sciences, and Viewpoint.

Crawford received his PhD in biochemistry from UCSF. Loves traveling with his family, making great pizza, and killer cappuccinos.

Linda Eng

Linda Eng

Business Manager

Linda Eng is Business Manager for QB3@953, managing space and lease interactions, application processes, and facilities. Linda is also the Office Manger for Mission Bay Capital, helping the venture team track investment deals, organize meetings, and provide administrative support.

She served as assistant to Douglas Crawford at QB3 years ago, where she helped Mission Bay Capital in its formation and launch. Thereafter, Linda was offered a role within UCSF’s Department if hematology and oncology as Program Manager of the Translational Research Program under the Alliance for Clinical Trials in Oncology, an NCI cooperative group. She managed the requests, approval process, and regulatory requirements for translational studies of biospecimens from all tumor types from the Alliance’s federated biorepositories. While there, her role grew into Program Manager of the Prostate Cancer Research Program for UCSF’s Helen Diller Family Comprehensive Cancer Center. Linda provided project management for a $10M Stand Up To Cancer Prostate Dream Team, a six-institution clinical trial effort to target treatment-resistant metastatic prostate cancer.

Linda enjoys reading, science fiction movies, British TV, time with family, and traveling.

team-QB3
Our Team: Anna Wong, Jason Irias, Michael Munchua, Linda Eng, Douglas Crawford, Antonio Solano, Fred Dizon, and Emma Matillano

Upcoming Event

  • Scalable Microbiome Diagnostics for Agriculture

    12:30-13:30
    09/21/2017
    1st Floor Conference Room, GEHC
    953 Indiana Street, San Francisco, CA 94107, United States
    AMGEN Lunch Seminar Diane Wu, PhD and Poornima Parameswaran, PhD Co-Founders, Trace Genomics RSVP The Trace Genomics microbiome sequencing platform enables screening of disease-causing microbes and interpretation of millions of beneficial organisms in the soil. Their machine learning platform enables simple integration of soil microbiome information into with field management information to help farmers identify optimal management conditions that increase soil health and sustainability as well as crop yields. Their innovative technology has received notable media coverage in Forbes, TechCrunch, Wall Street Journal, AgFunder, and Fast Company, and was most recently listed by Forbes as one of the 25 most innovative Ag Tech startups. About Diane Wu Diane Wu, PhD completed a BSc in Computer Science and Molecular Biology at SFU (Vancouver, Canada) and a PhD in Genetics at Stanford University. She was awarded a Stanford Graduate Fellowship and published her thesis on the cover of Nature Structural Molecular Biology, advised by Nobel Laureate Dr. Andrew Fire. Diane then joined the machine learning team at Palantir Technologies as one of their first data scientists, where she built predictive models for healthcare, merchandising, law enforcement, and fraud detection.
    About Poornima Parameswaran Poornima Parameswaran, PhD completed her BS in Molecular Biology at UT Austin, a PhD in Microbiology & Immunology at Stanford University with Nobel Laureate Dr. Andrew Fire, and her postdoctoral fellowship with MacArthur Fellow Dr. Eva Harris at UC Berkeley's school of Public Health, where she also worked with the Ministry of Health in Nicaragua. She has been an author on eleven publications (371+ citations), where she used NGS technologies in novel ways to address fundamental questions in pathogen-host interactions.

Address

953 Indiana St., San Francisco, CA 94107
Tel: (415)-347-8287
Map

Sign-Up for our Newsletter